Skip to content

Ayurvedic Management of Vicharchika (Eczema) by Panchashirisha agada & Vishaghna lepa.

Efficacy of Panchashirisha agada & Vishaghna lepa in the Management of Vicharchika w.s.r to Eczema - A Single arm Open-Labelled clinical trial. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066343
Enrollment
35
Registered
2024-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L249- Irritant contact dermatitis, unspecified cause

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having Classical sign & Symptoms of vicharchika like Shyavta, Rukshta, Pidaka, Vedana, Daha. 2.Having recurrent hisory of Eczema. 3.Having Vicharchika with in duration of one year.

Exclusion criteria

Exclusion criteria: 1.age below 18 & above 60 years. 2.Patients having Vicharchika more than the duration of one year. 3.Pregnant women. 4.Lactating mother 5.Patients suffering from Complicated systemic disease 6.Extensive infectious skin disorders ,Extensive dermatitis other than eczema. 7.patients who are willing for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Panchashirisha agada along with the Vishaghna lepa is effective in the management of Symtoms of Vicharchika(eczema)like Kandu,Pidaka,Shyavta,Daha,Rukshata,Vedana.Timepoint: 4 weeks

Secondary

MeasureTime frame
Study shall generate evidence based data in the context of improvement in the luster of the skin & colour of the skin.Hence,effectively improving the quality of life of patients.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactVd Charmi Mehta

Institute of Teaching and Research in Ayurveda

drsud@itra.edu.in9687792882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026